News

STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results

HORSHAM, Penn., July 11, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical…

1 year ago

Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024

NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated…

1 year ago

Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium

Hematology Oncology of Indiana’s M. Sarfraz Nawaz, MD, investigated improvement in approaches to febrile neutropenia in cancer patients Indianapolis Medical…

1 year ago

Acumen Pharmaceuticals to Present Patient Experience and Biomarker Insights from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024

NEWTON, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel…

1 year ago

Entero Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds

BOCA RATON, Fla., July 11, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (“Entero” or the “Company”) (NASDAQ: ENTO), a clinical-stage…

1 year ago

Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide

Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration Oak Ridge, TN, July 11, 2024 (GLOBE…

1 year ago

Derek Chaves Appointed Chief Financial Officer of Corza Medical

WESTWOOD, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”) is proud to announce the appointment…

1 year ago

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

This marks the first export into Asia, the 18th international market for Aureus branded products and 21st market for all…

1 year ago

Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th

SAN DIEGO, July 11, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on…

1 year ago